Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AGMT Austrian CLL (Chronic Lymphocytic Leukemia) Registry

NCT06250465 is registered in ClinicalTrials.gov with Arbeitsgemeinschaft medikamentoese Tumortherapie as lead sponsor.

NCT NCT06250465
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06250465 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AGMT Austrian CLL (Chronic Lymphocytic Leukemia) Registry
Lead sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Phase
Observational
Overall status
Recruiting
Start date
March 24, 2022
Completion date
December 31, 2027
Enrollment
500 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia